Antonio Brucato Selected Research

Interleukin 1 Receptor Antagonist Protein (Anakinra)

4/2022	Rapid resolution of severe pericardial effusion using anakinra in a patient with COVID-19 vaccine-related acute pericarditis relapse: a case report.
1/2022	Anakinra effectiveness in refractory polyserositis: An Italian multicenter study.
1/2022	Immunomodulating Therapies in Acute Myocarditis and Recurrent/Acute Pericarditis.
1/2022	Recent advances in pericarditis.
1/2022	Anti-interleukin-1 agents for pericarditis: a primer for cardiologists.
10/2021	[Anti-interleukin-1 agents: a new class of drugs for recurrent pericarditis. A practical guide for cardiologists].
3/2021	Anti-interleukin 1 agents for the treatment of recurrent pericarditis: a systematic review and meta-analysis.
1/2021	COVID-19 Disease in Patients With Recurrent Pericarditis During Treatment With Anakinra: Comment on the Article by Navarro-Millán et al.
1/2021	Autoimmune and Autoinflammatory Pericarditis: Definitions and New Treatments.
1/2021	Case Report: Pericardial Effusion Treated With Pericardiectomy Plus Right Atrial Mass Resection: A 2-Year Follow-Up of Cardiac Rosai-Dorfman Disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Antonio Brucato Research Topics

Disease

63	Pericarditis 04/2022 - 06/2004
14	Inflammation (Inflammations) 05/2022 - 04/2010
13	Congenital heart block 01/2019 - 01/2002
10	COVID-19 10/2022 - 01/2020
9	Fever (Fevers) 01/2022 - 07/2012
8	Pericardial Effusion 04/2022 - 11/2010
7	Myocarditis (Carditis) 04/2022 - 12/2002
6	Autoimmune Diseases (Autoimmune Disease) 01/2018 - 09/2005
5	Neonatal Systemic lupus erythematosus 01/2019 - 01/2002
5	Atrial Fibrillation 01/2018 - 11/2011
5	Familial Mediterranean Fever (Periodic Disease) 01/2018 - 01/2008
5	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 12/2015 - 11/2010
4	Cardiac Tamponade 01/2021 - 08/2012
4	Postpericardiotomy Syndrome 01/2018 - 11/2011
4	Thrombosis (Thrombus) 12/2015 - 11/2010
3	Rheumatic Diseases (Rheumatism) 01/2022 - 01/2006
3	Serositis 01/2022 - 03/2009
3	Heart Failure 01/2022 - 01/2018
3	Gout 07/2021 - 01/2018
3	Atrioventricular Block 04/2021 - 12/2002
3	Pneumonia (Pneumonitis) 01/2021 - 01/2020
3	Infections 01/2021 - 01/2020
3	Constrictive Pericarditis 10/2020 - 11/2010
3	Pregnancy Complications 12/2015 - 12/2012
3	Pleural Effusion (Pleural Effusions) 09/2014 - 09/2011
2	Cytokine Release Syndrome 04/2022 - 01/2020
2	Injection Site Reaction 10/2021 - 01/2021
2	Respiratory Tract Infections (Respiratory Tract Infection) 10/2021 - 01/2021
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2021 - 10/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2018
2	Amyloidosis 01/2021 - 01/2021
2	Pain (Aches) 10/2020 - 02/2015
2	Acute Coronary Syndrome 10/2020 - 07/2013
2	Coronary Artery Disease (Coronary Atherosclerosis) 10/2020 - 01/2018
2	Myocardial Infarction 01/2020 - 01/2018
2	Edema (Dropsy) 01/2020 - 06/2009
2	Hypertension (High Blood Pressure) 01/2019 - 06/2011
2	HELLP Syndrome 01/2019 - 10/2010
2	Heart Diseases (Heart Disease) 01/2018 - 09/2015
2	Cryopyrin-Associated Periodic Syndromes 01/2018 - 01/2013
2	Vasculitis (Vasculitides) 09/2015 - 02/2015
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 05/2015 - 10/2014
1	Leukopenia 10/2021
1	Leukocytosis (Pleocytosis) 10/2021
1	Anemia 01/2021
1	Obesity 01/2021
1	Sinus Histiocytosis (Rosai-Dorfman Disease) 01/2021
1	Rupture 10/2020

Drug/Important Bio-Agent (IBA)

43	Colchicine FDA LinkGeneric 10/2022 - 04/2005
22	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 04/2005
20	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 04/2022 - 01/2013
12	Pharmaceutical PreparationsIBA 09/2021 - 01/2006
11	C-Reactive ProteinIBA 01/2022 - 03/2011
11	Interleukin-1 (Interleukin 1)IBA 01/2022 - 01/2018
10	AntibodiesIBA 04/2021 - 12/2002
7	rilonacept FDA Link 01/2022 - 10/2020
6	SteroidsIBA 01/2022 - 06/2009
5	Biological ProductsIBA 01/2022 - 01/2013
5	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2021 - 02/2016
5	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019 - 10/2010
5	SS-A antibodiesIBA 11/2017 - 01/2002
4	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 04/2022 - 01/2018
4	InflammasomesIBA 01/2022 - 10/2020
4	AutoantibodiesIBA 01/2019 - 01/2002
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2002
3	InterleukinsIBA 01/2022 - 11/2016
3	Transaminases (Aminotransferases)IBA 10/2021 - 11/2016
3	CytokinesIBA 01/2021 - 01/2018
3	TroponinIBA 01/2020 - 07/2013
3	Ibuprofen (Motrin)FDA LinkGeneric 01/2020 - 10/2013
3	Biomarkers (Surrogate Marker)IBA 04/2016 - 03/2013
3	Antiphospholipid AntibodiesIBA 12/2015 - 09/2005
2	GadoliniumIBA 05/2022 - 01/2020
2	VaccinesIBA 04/2022 - 01/2021
2	AlbuminsIBA 01/2022 - 01/2020
2	Amyloid (Amyloid Fibrils)IBA 01/2021 - 01/2021
2	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2020 - 01/2019
2	AnticoagulantsIBA 01/2018 - 04/2016
2	Indomethacin (Indometacin)FDA LinkGeneric 01/2017 - 06/2014
2	Immunosuppressive Agents (Immunosuppressants)IBA 09/2015 - 07/2012
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2015 - 02/2015
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 09/2015 - 08/2014
1	Messenger RNA (mRNA)IBA 04/2022
1	COVID-19 VaccinesIBA 04/2022
1	Methylprednisolone FDA LinkGeneric 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	fibrin fragment D (D-dimer)IBA 01/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021
1	BNT162 VaccineIBA 01/2021
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2021
1	Lopinavir FDA Link 10/2020
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2020
1	Interleukin-18 (Interleukin 18)IBA 10/2020

Therapy/Procedure

37	Therapeutics 01/2022 - 06/2004
5	Pericardiectomy 01/2021 - 11/2010
3	Secondary Prevention 12/2014 - 10/2011
2	Catheters 01/2021 - 01/2021
2	Drug Therapy (Chemotherapy) 01/2020 - 01/2018
2	Length of Stay 01/2018 - 08/2012
2	Contraindications 02/2016 - 06/2014